We further demonstrated that ADAM9 could inhibit the expression of miR-218 and its precursor pri-miR-218-1 and could, in turn, up-regulate the expression of CDH2 to increase the mobility of lung adenocarcinoma cells. This evidence concerns the gene ADAM9 and lung adenocarcinoma.